Your session is about to expire
← Back to Search
Corneal Gas Permeable Lenses for Keratoconus
Study Summary
This trial is comparing two methods of correcting vision for people with keratoconus, a condition where the shape of the cornea becomes irregular. The study will compare how well each method works and how satisfied patients are with their vision.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with keratoconus.I have never had corneal transplantation or INTACS.I have scarring on my cornea.You have a measurement of the shape and thickness of your cornea before starting the study.I have been diagnosed with keratoconus.
- Group 1: Corneal gas permeable lens first
- Group 2: Scleral lens first
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment open at this time for the trial?
"Per the details hosted on clinicaltrials.gov, this medical study is actively seeking out patients to parttake in their trials. It was first introduced on July 23rd 2021 and recently updated on May 18th 2022."
To what capacity is the current clinical trial being populated?
"Affirmative. Clinicaltrials.gov's records demonstrate that this trial, which first appeared online on July 23rd 2021, is still open for recruitment. 125 people are needed to be enrolled from 6 distinct locations."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Illinois at Chicago Eye and Ear Infirmary: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger